GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
54 hedge funds and large institutions have $38M invested in Aevi Genomic Medicine Inc in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
22% less call options, than puts
Call options by funds: $62K | Put options by funds: $79K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
54
Holding in Top 10
–
Calls
$62K
Puts
$79K
Top Buyers
| 1 | +$2.46M | |
| 2 | +$1.23M | |
| 3 | +$654K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$565K |
| 5 |
BC
Broadfin Capital
New York
|
+$545K |
Top Sellers
| 1 | -$1.79M | |
| 2 | -$1.41M | |
| 3 | -$1.07M | |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$338K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$314K |